TP53 and breast carcinoma: Genomic findings were consistent with our current understanding of the biology of breast cancer, including an adverse association between TGFβ and p53 signaling and a favorable association with androgen receptor signaling and immune infiltration, particularly macrophages and cytotoxic T cells.